JPX · 4595.T
Mizuho Medy Co.,Ltd.
¥1,711+¥10 (+0.59%)
Mizuho Medy Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 11.35% below the high.
Loading market information…
JPX · 2929.T · JPY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · JPY. Historical prices are not a forecast.
Pharma Foods International Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 23.12% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Pharma Foods International Co., Ltd.’s forward annual dividend is ¥25 per share, paid semi-annual. The forward yield is 3.94% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Pharma Foods International Co., Ltd.’s next earnings report is currently expected on Dec 16, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Pharma Foods International Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Pharma Foods International Co., Ltd. is a Japanese enterprise dedicated to the research, development, and commercialization of ingredients for functional foods. Its diverse product portfolio features items such as Pharma-GABA, Bonepep, Ovopron (a specific egg yolk globulin), Delicious Catechin, RunPep, and enriched Folic Acid Egg. Additionally, the company offers iHA, a compound recognized for stimulating the body's hyaluronic acid production. Furthermore, Pharma Foods International Co., Ltd. has entered into a licensing arrangement with Mitsubishi Tanabe Pharma Corporation for a novel therapeutic antibody designed to combat autoimmune conditions. The firm was founded in 1997 and maintains its corporate headquarters in Kyoto, Japan.
Latest available per-share figures in JPY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:11 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| ¥13 |
| ¥14.6B |
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
¥1,711+¥10 (+0.59%)
Mizuho Medy Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 11.35% below the high.
¥1,212¥0 (0.0%)
Saint-Care Holding Corporation’s quoted price sits in the lower half of its reported 52-week range, 100.0% below the high.
¥2,712+¥119 (+4.59%)
FALCO HOLDINGS Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 8.5% below the high.
¥192-¥8 (-4.0%)
CYBERDYNE Inc.’s quoted price sits in the lower half of its reported 52-week range, 54.29% below the high.
¥491+¥4 (+0.82%)
Kanamic Network Co.,LTD’s quoted price sits in the lower half of its reported 52-week range, 15.78% below the high.
¥856+¥8 (+0.94%)
FINDEX Inc.’s quoted price sits in the lower half of its reported 52-week range, 15.33% below the high.
¥2,107-¥3 (-0.14%)
Fuso Pharmaceutical Industries,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 16.72% below the high.
¥971-¥28 (-2.8%)
Renascience Inc.’s quoted price sits in the lower half of its reported 52-week range, 56.42% below the high.
